Tom Mirga
Editor at Large
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...] …
Category: Non-Governmental
Tom Mirga
Editor at Large
Tom Mirga
Editor at Large
Seema Verma, ex-President Trump’s Centers for Medicare & Medicaid Services administrator, said in a Wall Street Journal op-ed yesterday that large health systems work to expand their use of the 340B program “and thus their profit and monopoly power.”
“Across
…
Sarah True
Editor at Large
Advocacy organization Community Voices for 340B (CV340B) is hosting a march to the U.S. Capitol “to defend 340B” on Aug. 3 just after the 340B Coalition annual summer meeting in nearby National Harbor, Md., concludes.
CV340B, a nonprofit organization supported
… Tom Mirga
Editor at Large
340B Report held a webinar for its subscribers last week on Second Sight Solutions’ 340B ESP platform that administers drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies. More than 800 subscribers registered to attend—a clear sign
… Tom Mirga
Editor at Large
America’s oldest consumer protection group, shunned by some former allies in the labor movement for alleged favoritism toward its corporate donor Amazon, has slammed the 340B program in a commentary for the conservative-leaning news and opinion website RealClearHealth.
“Sadly, as
… Tom Mirga
Editor at Large
Charity care has been declining significantly in some Massachusetts hospital systems, raising “a significant policy issue for the 340B program,” a free-market-oriented Massachusetts think tank whose donors include pharmaceutical manufacturers says in a new report.
The state hospital association said
…HIV/AIDS Advocates Protest in Front of Gilead HQ Against Company’s New 340B Contract Pharmacy Policy
Tom Mirga
Editor at Large
UPDATE Thursday, March 24, 2022, 2:10 p.m.—A Gilead spokesperson disputed AIDS Healthcare Foundation’s statement that, under Gilead’s new conditions on 340B contract pharmacy pricing on its branded hepatitis C treatments, the company will give 340B discounts to covered entities only
… Tom Mirga
Editor at Large
AIDS Healthcare Foundation (AHF) today criticized efforts to introduce federal legislation to address drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies. It said the drug industry “will certainly use any legislation as an opportunity to further
… Tom Mirga and Ron Shinkman
Editor at Large
Prospects for passage of Democratic drug pricing legislation as part of the Build Back Better (BBB) Act dimmed again last week with news that Sen. Ben Ray Lujan (D-N.M.) had a stroke on Jan 27.
Lujan’s chief of staff
The Institute for Clinical and Economic Review (ICER) has issued a draft report concluding four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients. The independent nonprofit group evaluates prescription drugs and medical treatments’ cost effectiveness
…